Contraception News and Research

Latest Contraception News and Research

FDA approves change to prescribing information for Gilead Sciences' Letairis

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.

5 Mar 2011

Viewpoints: Obama's 'flexibility' offer; Virginia's abortion law 'mischief'; primary care cuts

President Obama had a splendid idea this week. He challenged governors who oppose his health care reforms, most of whom are Republicans, to come up with a better alternative.

3 Mar 2011

U.S. District Court rules in favor of Hologic in breast brachytherapy patent infringement lawsuit

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the United States Court of Appeals for the Federal Circuit has ruled in favor of Hologic, by reversing the previous decisions reached by the United States District Court for the Northern District of California, in favor of SenoRx, Inc.

From Hologic, Inc. 28 Feb 2011

Conceptus announces CE mark approval for use of Transvaginal Ultrasound in Essure procedure

Conceptus Inc., developer of the Essure procedure, the most effective non-surgical permanent birth control method available, today announced receipt of the CE mark for use of Transvaginal Ultrasound to confirm proper placement of Essure micro-inserts three months following the Essure procedure.

24 Feb 2011

UCSF study shows increased contraceptive supply decreases unintended pregnancy rates

Rates of unintended pregnancies and abortions decrease significantly when women receive a one-year supply of oral contraceptives, instead of being prescribed one- or three-month supplies, a UCSF study shows.

24 Feb 2011

New research suggests prevention of unwanted births may decline fertility rates

While many researchers generally credit the desire for smaller families for the decline in fertility rates in developing, low-income countries, new research suggests that prevention of unwanted births may actually be a larger factor.

21 Feb 2011

HHS overturns Bush 'conscience' rule for workers opposing abortion

The Obama administration on Friday rescinded most of a 2008 rule that granted sweeping protections to health care providers who opposed abortion, sterilization and other medical procedures on religious or moral grounds.

20 Feb 2011

Planned Parenthood funding sparks passionate debate on House floor

Almost unnoticed in the wars over the federal budget has been a pitched battle over money for Planned Parenthood, which provides contraception, medical services and abortions at 800 clinics around the country. ... At stake is more than $75 million that Planned Parenthood receives to provide family planning assistance to low-income women, money that its opponents say only frees up funds for abortions (Eckholm, 2/17).

19 Feb 2011

Viewpoints: Budget disappointment; supporting CLASS Act; health law's Medicaid 'mess'

If fiscal sanity is to be restored, Americans need to be told the hard facts — not just that the national debt is out of control and that deficits can't go on and on, but that getting the nation's finances in order will require going everywhere in the budget: domestic programs, defense spending and the big entitlement programs such as Social Security, Medicare and Medicaid that already consume three of every five dollars the government spends.

16 Feb 2011

Girls Decide: Putting girls' sexual and reproductive health at the heart of development

There is a growing global consensus that girls are central to global development. Yet issues relating to girls’ sexuality and their sexual and reproductive rights continue to be largely neglected. Girls Decide, a new initiative from the International Planned Parenthood Federation (IPPF), highlights the importance of girls’ and young women’s sexual and reproductive lives for both individual and global development, and aims to ensure governments around the world to adopt policies that work for girls.

15 Feb 2011

A ‘Condom Finder’ app launched

The New York City Health Department on Valentine’s Day launched a smart phone application that will help users locate the nearest place in the area giving out free condoms.

14 Feb 2011

FDA approves Hologic's 3-D digital mammography system to diagnose breast cancer

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the Company received approval from the U.S. Food and Drug Administration for its Selenia Dimensions digital breast tomosynthesis system.

From Hologic, Inc. 14 Feb 2011

Hologic receives FDA approval for hydroxyprogesterone caproate injection

Hologic, a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the U.S. Food and Drug Administration has approved Hologic's pharmaceutical named Makena, formerly known as Gestiva.

From Hologic, Inc. 4 Feb 2011

Enrollment stopped in one of two global necitumumab Phase III studies in NSCLC

Eli Lilly and Company and Bristol-Myers Squibb Company announced today that they have stopped enrollment in one of their two global Phase III studies evaluating necitumumab, an investigational anti-cancer agent, as a first-line treatment for advanced non-small cell lung cancer (NSCLC).

3 Feb 2011

Easier access to emergency birth control increases sexually-transmitted diseases among teenagers

Offering the morning after pill free over the counter has not reduced the number of teenage pregnancies and may be associated with a rise in sexually-transmitted diseases (STIs), according to a report by experts at The University of Nottingham.

1 Feb 2011

New feature: KHN's selection of thought-provoking magazine articles on health policy issues

Today, we begin this new weekly feature, which will provide a selection of thought-provoking articles from a variety of sources.

29 Jan 2011

Family physicians often uncomfortable in discussing IUDs with patients

Intrauterine devices (IUDs) for contraception are safe and effective, but only a small fraction of women in the United States use them.

13 Jan 2011

Hologic announces acquisition of Interlace Medical

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today it has acquired Interlace Medical, Inc. (Interlace), the developer and manufacturer of the MyoSure hysteroscopic tissue removal system (MyoSure). Interlace's operations will be integrated within Hologic's GYN Surgical Products division.

From Hologic, Inc. 7 Jan 2011

Problems reported with Implanon contraceptive implant

Quite a few women have reported accidental and unwanted pregnancies while using Implanon, a hormone implant injected into the arm which is designed to last three years. Although the hormonal implant is described to be 99% effective, is thought to be due to problems with the initial implantation, rather than its efficacy once correctly inserted beneath the skin.

6 Jan 2011

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

Contraception News and Research

Latest Contraception News and Research

FDA approves change to prescribing information for Gilead Sciences' Letairis

Viewpoints: Obama's 'flexibility' offer; Virginia's abortion law 'mischief'; primary care cuts

U.S. District Court rules in favor of Hologic in breast brachytherapy patent infringement lawsuit

Conceptus announces CE mark approval for use of Transvaginal Ultrasound in Essure procedure

UCSF study shows increased contraceptive supply decreases unintended pregnancy rates

New research suggests prevention of unwanted births may decline fertility rates

HHS overturns Bush 'conscience' rule for workers opposing abortion

Planned Parenthood funding sparks passionate debate on House floor

Viewpoints: Budget disappointment; supporting CLASS Act; health law's Medicaid 'mess'

Girls Decide: Putting girls' sexual and reproductive health at the heart of development

A ‘Condom Finder’ app launched

FDA approves Hologic's 3-D digital mammography system to diagnose breast cancer

Hologic receives FDA approval for hydroxyprogesterone caproate injection

Enrollment stopped in one of two global necitumumab Phase III studies in NSCLC

Easier access to emergency birth control increases sexually-transmitted diseases among teenagers

New feature: KHN's selection of thought-provoking magazine articles on health policy issues

Family physicians often uncomfortable in discussing IUDs with patients

Hologic announces acquisition of Interlace Medical

Problems reported with Implanon contraceptive implant

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Contraception News and Research

Latest Contraception News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in